Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
Open-market buys, last 90 days
$1,379,662
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thermopylae Holdings Ltd. +$699K 10% owner 1 filing
  2. Hayden Michael R +$570K Director 1 filing
  3. Montalbano John S. +$110K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2020-12-15 DCVC Bio, L.P. 10% owner Conversion · Convertible Note −0 0
2020-12-15 THIEL PETER Director Conversion +3,811,260 4,702,780
2020-12-15 THIEL PETER Director Conversion +2,477,100 7,179,880
2020-12-15 THIEL PETER Director Purchase +3,000,000 $20.00 $60.0M 10,179,880
2020-12-15 THIEL PETER Director Conversion +3,343,240 3,343,240
2020-12-15 THIEL PETER Director Conversion +401,050 401,050
2020-12-15 THIEL PETER Director Conversion +29,240 29,240
2020-12-15 THIEL PETER Director Conversion +382,357 382,357
2020-12-15 THIEL PETER Director Conversion +24,660 24,660
2020-12-15 THIEL PETER Director Conversion · Series A2 Preferred Shares −381,126 0
2020-12-15 THIEL PETER Director Conversion · Series A2 Preferred Shares −334,324 0
2020-12-15 THIEL PETER Director Conversion · Series A2 Preferred Shares −40,105 0
2020-12-15 THIEL PETER Director Conversion · Series A2 Preferred Shares −2,924 0
2020-12-15 THIEL PETER Director Conversion · Convertible Note −0 0
2020-12-15 THIEL PETER Director Conversion · Convertible Note −0 0
2020-12-15 THIEL PETER Director Conversion · Convertible Note −0 0
2020-12-15 HAMER JOHN Director Conversion +29,076,350 29,076,350
2020-12-15 HAMER JOHN Director Conversion +29,411 29,105,761
2020-12-15 HAMER JOHN Director Conversion · Series A1 Preferred Shares −2,105,264 0
2020-12-15 HAMER JOHN Director Conversion · Series A2 Preferred Shares −802,371 0

Page 9 of 11 · 203 trades